Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio M Pimentel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Cell Physiology|April 22, 2024
Ubiquitin-driven G protein-coupled receptor inflammatory signaling at the endosomeNorton Cheng, Julio M Pimentel, JoAnn Trejo
Molecular Carcinogenesis|October 14, 2022
Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancers|June 22, 2023
The Role of TRAIL in Apoptosis and Immunosurveillance in CancerJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancer Letters|October 12, 2024
Autophagy and cancer therapyJulio M Pimentel, Jun Ying Zhou, Gen Sheng Wu
American Journal of Cancer Research|November 16, 2023
The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Seongho Kim, et al.
Cell Cycle (Georgetown, Tex.)|February 4, 2020
Targeting PP2A inhibits the growth of triple-negative breast cancer cellsMohammed Hafiz Uddin, Julio M Pimentel, Madhumita Chatterjee, et al.
Current Issues in Molecular Biology|October 28, 2025
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78Madhumita Chatterjee, Julio M Pimentel, Jun-Ying Zhou, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Cell Physiology|April 22, 2024
Ubiquitin-driven G protein-coupled receptor inflammatory signaling at the endosomeNorton Cheng, Julio M Pimentel, JoAnn Trejo
Molecular Carcinogenesis|October 14, 2022
Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancers|June 22, 2023
The Role of TRAIL in Apoptosis and Immunosurveillance in CancerJulio M Pimentel, Jun-Ying Zhou, Gen Sheng Wu
Cancer Letters|October 12, 2024
Autophagy and cancer therapyJulio M Pimentel, Jun Ying Zhou, Gen Sheng Wu
American Journal of Cancer Research|November 16, 2023
The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Seongho Kim, et al.
Cell Cycle (Georgetown, Tex.)|February 4, 2020
Targeting PP2A inhibits the growth of triple-negative breast cancer cellsMohammed Hafiz Uddin, Julio M Pimentel, Madhumita Chatterjee, et al.
Current Issues in Molecular Biology|October 28, 2025
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78Madhumita Chatterjee, Julio M Pimentel, Jun-Ying Zhou, et al.
Pageof 1